Evidence map›Paper›PMID 19450496›Full record

ArticleBiophysical journal2009

Two distinct conformations of Abeta aggregates on the surface of living PC12 cells.

David A Bateman, Avijit Chakrabartty

Abstract read
In one paragraph

Article in Biophysical journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Glucose directs amyloid-beta into membrane-active oligomers.Physical chemistry chemical physics : PCCP · 2017
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David A BatemanDepartment of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Avijit Chakrabartty

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abeta42 has been found to associate rapidly to neuronal cells and is the primary constituent of senile plaques. In this study we monitored the aggregation of Abeta42 with living PC12 cells. Using photobleaching Förster resonance energy transfer, we observed one set of aggregates that displayed colocalization and another that displayed energy transfer. Cell surface aggregates were found to become resistant to potassium iodide (KI)-induced quenching. Exposed Abeta42 regions were probed with three monoclonal antibodies directed against the N-terminus, an internal sequence, and the C-terminus of Abeta42. Two populations of aggregates were revealed: one that bound all three antibodies, and one that bound all but the C-terminus antibody. Of interest, using fluorescent recovery after photobleaching, we observed no Abeta42 exchange within either type of aggregate. These findings offer what we believe is new insight into the conformations of Abeta42 that accumulate on the surface of living cells. One conformation is incapable of energy transfer, is sensitive to KI, and binds C-terminus-specific antibodies. The other conformation increases in number over time, is capable of energy transfer, is quencher-resistant, and has a sequestered C-terminus. With further studies to characterize Abeta aggregation on live cells, the underlying mechanisms leading to Alzheimer's disease may be revealed.

Indexed as

Amyloid beta-PeptidesAnimalsAntibodies, MonoclonalAntibody SpecificityCell SurvivalFluorescence Recovery After PhotobleachingFluorescence Resonance Energy TransferPC12 CellsPeptide FragmentsProtein BindingProtein Structure, TertiaryProtein TransportRatsAmyloid beta-Peptidesamyloid beta-protein (1-42)Antibodies, MonoclonalPeptide Fragments

Identifiers

PMID19450496
PMCPMC2712147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.